Medicine & Life Sciences
Liver Transplantation
100%
Hepacivirus
74%
Hepatitis C
56%
Antiviral Agents
56%
Hepatocellular Carcinoma
55%
Fibrosis
54%
Guidelines
45%
Hepatitis B
42%
Liver
39%
entecavir
39%
Liver Diseases
34%
Sustained Virologic Response
34%
Therapeutics
33%
Chronic Hepatitis B
31%
Transplant Recipients
29%
Gastroenterologists
28%
Yttrium-90
27%
Virus Diseases
25%
Chronic Hepatitis C
25%
Hepatitis B virus
25%
Portal Vein
24%
Alcoholic Liver Diseases
24%
Hemochromatosis
23%
Barrett Esophagus
22%
Alcoholic Hepatitis
22%
Esophageal and Gastric Varices
22%
Hepatic Encephalopathy
22%
Ribavirin
21%
Ascites
19%
Immunoglobulins
18%
Thrombosis
18%
Portal Hypertension
16%
Tissue Donors
16%
Acute Liver Failure
16%
Liver Cell Adenoma
15%
Focal Nodular Hyperplasia
15%
Sofosbuvir
15%
Liver Circulation
15%
Recurrence
15%
Superior Mesenteric Artery Syndrome
15%
N-acetyltalosaminuronic acid
14%
Practice Guidelines
14%
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
14%
Surgical Splenorenal Shunt
14%
Hepatitis
14%
Neonatal hemochromatosis
14%
retinol palmitate
14%
telaprevir
13%
Splanchnic Circulation
13%
Biopsy
13%